Cargando…
Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
BACKGROUND: Topical glucocorticosteroids are the first line therapy for airway inflammation. Modern compounds with higher efficacy have been developed, but head-to-head comparison studies are sparse. OBJECTIVE: To compare the activity of two intranasal glucocorticoids, fluticasone furoate (FF) and m...
Autores principales: | Zhang, Nan, Van Crombruggen, Koen, Holtappels, Gabriele, Lan, Feng, Katotomichelakis, Michail, Zhang, Luo, Högger, Petra, Bachert, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977874/ https://www.ncbi.nlm.nih.gov/pubmed/24710117 http://dx.doi.org/10.1371/journal.pone.0093754 |
Ejemplares similares
-
Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013) -
A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016) -
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021) -
Significant receptor affinities of metabolites and a degradation product of mometasone furoate
por: Valotis, Anagnostis, et al.
Publicado: (2004) -
Mometasone furoate nasal spray: a systematic review
por: Passali, Desiderio, et al.
Publicado: (2016)